Bitcoin price today: falls to 2-week low below $113k ahead of Fed Jackson Hole
Investing.com -- Scienture Holdings Inc (NASDAQ:SCNX) stock plummeted 43.7% after the pharmaceutical holding company announced a registered direct offering of common stock at a significant discount to its market price.
The company revealed it has entered into a securities purchase agreement with institutional investors to sell 3,225,000 shares of common stock at $1.20 per share. The offering, expected to close on August 15, 2025, aims to raise approximately $3.9 million in gross proceeds before deducting placement agent fees and other expenses.
The offering price of $1.20 represents a substantial discount compared to Scienture’s previous trading levels, triggering the sharp selloff. Maxim Group LLC is serving as the sole placement agent for the transaction.
Scienture Holdings describes itself as a holding company for existing and planned pharmaceutical operations that focuses on developing, marketing, and distributing novel specialty products to meet unmet market needs. The company trades on the Nasdaq under the ticker SCNX.
The offering is subject to customary closing conditions, according to the company’s announcement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.